Works matching IS 14642662 AND DT 2018 AND VI 19 AND IP 3

Results: 11

Hospital‐based routine HIV testing in high‐income countries: a systematic literature review.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. 195, doi. 10.1111/hiv.12568
By:
- Elgalib, A.;
- Fidler, S.;
- Sabapathy, K.
Publication type:
Article
Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. 184, doi. 10.1111/hiv.12567
By:
- Stirrup, O. T.;
- Copas, A. J.;
- Phillips, A. N.;
- Gill, M. J.;
- Geskus, R. B.;
- Touloumi, G.;
- Young, J.;
- Bucher, H. C.;
- Babiker, A. G.;
- CASCADE Collaboration in EuroCoord
Publication type:
Article
Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. 175, doi. 10.1111/hiv.12566
By:
- Jao, J.;
- Yu, W.;
- Patel, K.;
- Miller, T. L.;
- Karalius, B.;
- Geffner, M. E.;
- DiMeglio, L. A.;
- Mirza, A.;
- Chen, J. S.;
- Silio, M.;
- McFarland, E. J.;
- Van Dyke, R. B.;
- Jacobson, D.;
- the Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) study
Publication type:
Article
Issue Information.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. 1, doi. 10.1111/hiv.12549
Publication type:
Article
Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. 227, doi. 10.1111/hiv.12571
By:
- Rosenthal, E.;
- Fougerou‐Leurent, C.;
- Renault, A.;
- Carrieri, M. P.;
- Marcellin, F.;
- Garraffo, R.;
- Teicher, E.;
- Aumaitre, H.;
- Lacombe, K.;
- Bailly, F.;
- Billaud, E.;
- Chevaliez, S.;
- Dominguez, S.;
- Valantin, M. A.;
- Reynes, J.;
- Naqvi, A.;
- Cotte, L.;
- Metivier, S.;
- Leroy, V.;
- Dupon, M.
Publication type:
Article
Management of drug interactions with direct‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. 216, doi. 10.1111/hiv.12570
By:
- Smolders, E. J.;
- Smit, C.;
- de Kanter, C. T. M. M.;
- Dofferhoff, A. S. M.;
- Arends, J. E.;
- Brinkman, K.;
- Rijnders, B.;
- van der Valk, M.;
- Reiss, P.;
- Burger, D. M.;
- the ATHENA National HIV Observational Cohort
Publication type:
Article
HbAHP‐25 attenuates HIV‐1 gp120 mediated inflammation and barrier dysfunction.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. 206, doi. 10.1111/hiv.12569
By:
- Bashir, T.;
- Reddy, K. V. R.
Publication type:
Article
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. 238, doi. 10.1111/hiv.12545
By:
- Cuzin, L.;
- Yazdanpanah, Y.;
- Huleux, T.;
- Cotte, L.;
- Pugliese, P.;
- Allavena, C.;
- Reynes, J.;
- Poizot‐Martin, I.;
- Bani‐Sadr, F.;
- Delpierre, C.;
- the Dat'AIDS Study Group
Publication type:
Article
Now is the Time to Study the Timing of Influenza Vaccine.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. e53, doi. 10.1111/hiv.12486
By:
- Glinka, E. R.;
- Smith, D. M.;
- Johns, S. T.
Publication type:
Article
Response to Glinka <italic>et al</italic>. “Timing matters ‐ influenza vaccination to HIV‐infected patients”.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. e52, doi. 10.1111/hiv.12485
By:
- Williams, C.
Publication type:
Article
HIV testing in persons diagnosed with hepatitis B and C.
Published in:
HIV Medicine, 2018, v. 19, n. 3, p. e54, doi. 10.1111/hiv.12525
By:
- Ireland, G.;
- Ogaz, D.;
- Kirwan, P.;
- Mandal, S.;
- Delpech, V.;
- Connor, N.;
- Simmons, R.
Publication type:
Article